TransUnion (TRU) Acquires Healthcare Revenue Technologies in ~$62M Deal
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
TransUnion (NYSE: TRU), has acquired RTech (Healthcare Revenue Technologies, Inc), a technology-driven healthcare services company that offers post-service eligibility solutions designed to maximize reimbursements and reduce uncompensated care costs for hospitals and healthcare systems of all sizes.
TransUnion is investing in building its healthcare business because of the enormous opportunity to leverage data, technology and analytics to help healthcare providers maximize reimbursement. In June, TransUnion announced the acquisition of Auditz, LLC, another leading healthcare services organization.
"The right data and technology can offer great insights to help healthcare providers maximize reimbursement and cash flow -- enabling them to put more focus on the patient," said Jim Peck, TransUnion's president and chief executive officer. "Joining forces with RTech and Auditz adds powerful new capabilities to our already-strong healthcare business, consistent with our long-term strategy."
RTech is a market leader in the Northeast region of the United States and will augment TransUnion's healthcare solutions in three key ways:
- RTech's innovative Revenue Protection solution offers a more holistic view and analysis of hospital accounts receivables, allowing earlier detection and prevention of bad debt.
- RTech has developed unique new solutions for academic medical centers, as evidenced by their strong presence in that market.
- RTech's proprietary coverage discovery technology is a great complement to TransUnion's eScan product, as well as Auditz' solution, and TransUnion will integrate all three into a common coverage discovery offering to maximize benefits to clients.
"RTech has impressive solutions and a great track record of helping healthcare providers maximize reimbursement," said Gerry McCarthy, president of TransUnion Healthcare. "Revenue cycle management is a growing opportunity for healthcare providers, and we're excited to bring RTech onboard to enhance the solutions we offer our clients."
RTech will broaden its product line to offer many TransUnion solutions designed to empower healthcare providers to make smarter decisions at the point of service, including ClearIQ patient access products such as:
- Identity Verification, which helps verify patient identity;
- Insurance Eligibility, which helps confirm insurance benefits electronically;
- Patient Payment Estimation, which helps hospitals provide accurate estimates to patients; and
- Propensity to Pay, which helps determine patient ability and likelihood to pay.
"Joining TransUnion is an exciting milestone for RTech," said Todd Langer, president, RTech. "We have built our business on a foundation of innovative solutions for our clients, and look forward to delivering even more value with our combined solutions."
TransUnion's industry leading revenue cycle management solutions have resulted in nearly $1.3 billion in reimbursement to its clients. Combining the solutions of TransUnion, RTech and Auditz will yield additional recoveries for healthcare providers.
Item 1.01 Entry into a Material Definitive Agreement.
On September 21, 2016, TransUnion Healthcare, Inc. (“TransUnion Healthcare”), a subsidiary of TransUnion, entered into a Purchase Agreement, dated September 21, 2016 (the “Purchase Agreement”), by and among TransUnion Healthcare, Inc., RTech Healthcare Revenue Technologies, Inc. (“RTech”), John J. DeRuzza and Todd H. Langer, as Sellers, and Todd H. Langer, as the Seller Representative. RTech is a technology-driven healthcare services company that offers post-service eligibility solutions designed to maximize reimbursements and reduce uncompensated care costs for hospitals and healthcare systems of all sizes.
Pursuant to the Purchase Agreement, TransUnion Healthcare purchased 100% of the outstanding capital stock of RTech (the “Acquisition”) for consideration consisting of approximately $51.9 million paid at closing. TransUnion Healthcare also agreed to pay up to an additional $6.2 million, deposited in escrow at closing, upon satisfaction of specified conditions relating to customer retention, and up to an additional $3.9 million with respect to RTech accounts receivable that are collected after the closing date.
The Purchase Agreement contains customary representations and warranties, covenants and indemnities by both parties.
The foregoing description of the Purchase Agreement is a summary and is qualified in its entirety by reference to the Purchase Agreement, which is included as Exhibit 2.1 hereto and is incorporated herein by reference.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Providence & Worcester (PWX) Receives Shareholder Approval of Genesee & Wyoming (GWR) Deal
- A.O. Smith (AOS) Tops Q3 EPS by 2c; Guides In-Line
- Rexahn Pharma (RNN) Announces Receipt of U.S. Patent Related to RX-21101
Create E-mail Alert Related CategoriesCorporate News, Guidance, Management Comments, Mergers and Acquisitions
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!